High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease

Clinical Rheumatology

Volumn 27, Issue 7, 2008, Pages 845-850

  Borzutzky, Arturo ^a   Gutiérrez, Miguel ^a   Talesnik, Eduardo ^a   Godoy, Iván ^a   Kraus, Jonathan ^a   Hoyos, Rodrigo ^a   Arnaiz, Pilar ^a   Acevedo, Mónica ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Cardiovascular risk; Endothelial dysfunction; Flow mediated dilatation; High sensitivity C reactive protein; Kawasaki disease; Lipid profile

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; AGE; ARTERY BLOOD FLOW; ARTERY DILATATION; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHILE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; ECHOGRAPHY; FEMALE; HUMAN; LIPID BLOOD LEVEL; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM;

ADOLESCENT; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHILD; CHILE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROSPECTIVE STUDIES; VASODILATION;

EID: 45049088707     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0808-6     Document Type: Article

References (25)

1. Newburger JW, Takahashi M, Gerber MA et al (2004) Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 114:1708-1733
2. Kato H, Sugimura T, Akagi T et al (1996) Long-term consequences of Kawasaki disease. A 10-to 21-year follow-up study of 594 patients. Circulation 94:1379-1385
3. Deng YB, Li TL, Xiang HJ et al (2003) Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C. Pediatr Infect Dis J 22:34-39
4. Dhillon R, Clarkson P, Donald AE et al (1996) Endothelial dysfunction late after Kawasaki disease. Circulation 94:2103-2106
5. Kawasaki T (1967) Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children [in Japanese]. Arerugi 16:178
6. Ikemoto Y, Ogino H, Teraguchi M et al (2005) Evaluation of preclinical atherosclerosis by flow-mediated dilatation of the brachial artery and carotid artery analysis in patients with a history of Kawasaki disease. Pediatr Cardiol 26:782-786
7. Silva AA, Maeno Y, Hashmi A et al (2001) Cardiovascular risk factors after Kawasaki disease: A case-control study. J Pediatr 138:400-405
8. Kadono T, Sugiyama H, Hoshiai M et al (2005) Endothelial function evaluated by flow-mediated dilatation in pediatric vascular disease. Pediatr Cardiol 26:385-390
9. Noto N, Okada T, Yamasuge M et al (2001) Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics 107:1095-1099
10. Cheung YF, Ho MH, Tam SC et al (2004) Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 90:1281-1285
11. Ooyanagi R, Fuse S, Tomita H et al (2004) Pulse wave velocity and ankle brachial index in patients with Kawasaki disease. Pediatr Int 46:398-402
12. Newburger JW, Burns JC, Beiser AS et al (1991) Altered lipid profile after Kawasaki syndrome. Circulation 84:625-631
13. Mitani Y, Sawada H, Hayakawa H et al (2005) Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: Association between inflammation and late coronary sequelae in Kawasaki disease. Circulation 111:38-43
14. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555-576
15. Corretti MC, Anderson TJ, Benjamin EJ et al (2002) Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39:257-265
16. National Cholesterol Education Program (1992) Report of the expert panel on blood cholesterol levels in children and adolescents. Pediatrics 89(Suppl):525-584
17. Pearson TA, Mensah GA, Alexander RW et al (2003) Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
18. Ford ES, Ajani UA, Mokdad AH et al (2005) The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care 28:878-881
19. Acevedo M, Arnaiz P, Barja S et al (2007) Relationship of C-reactive protein to adiposity, cardiovascular risk factors and subclinical atherosclerosis in healthy children. Rev Esp Cardiol 60:1051-1058
20. Ford ES, Giles WH, Myers GL et al (2003) C-reactive protein concentration distribution among US children and young adults: Findings from the National Health and Nutrition Examination Survey, 1999-2000. Clin Chem 49:1353-1357
21. Albert MA, Ridker PM (2006) C-reactive protein as a risk predictor: Do race/ethnicity and gender make a difference? Circulation 114: E67-e74
22. Ridker PM, Wilson PW, Grundy SM (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109:2818-2825
23. Furuyama H, Odagawa Y, Katoh C et al (2003) Altered myocardial flow reserve and endothelial function late after Kawasaki disease. J Pediatr 142:149-154
24. Kavey RE, Allada V, Daniels SR et al (2006) Cardiovascular risk reduction in high-risk pediatric patients: A scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease
25. Graham TP Jr, Driscoll DJ, Gersony WM et al (2005) 36th Bethesda Conference: Recommendations for competitive athletes with cardiovascular disease: Task Force 2. J Am Coll Cardiol 45:1326-1333